Atlas Trials

Evaluation of the Effects of Cannabidiol (CBD) Compared to Delta-9-Tetrahydrocannabinol (THC) and Alprazolam

Clinical trial NCT03398083 · COMPLETED

Trial details

NCT number
NCT03398083
Sponsor
National Institute on Drug Abuse (NIDA)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cannabis Use Disorder
Start date
2017-12-04
Primary completion
2018-05-30
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.